Applied DNA Sciences, Inc. (NASDAQ: APDN) Climbs 33% After Exclusive Cannabis Licensing and Cooperation Agreement with TheraCann International

Applied DNA Sciences, Inc.

Applied DNA Sciences, Inc. (NASDAQ: APDN) is engaged within the research and development of PCR-based DNA manufacturing for authenticity and traceability product solutions. Shares of the anti-counterfeiting and anti-theft technology company climbed 33.36%, during trading on Friday, March 29, 2019. Over the past three months, Applied DNA Sciences has seen average daily volume of 532,590 shares. However, volume of 12.31…

Read More